UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2003
Commission File No. 0-16614
NEORX CORPORATION
(Exact name of Registrant as specified in its charter)
|
Washington |
|
91-1261311 |
|
(State or other
jurisdiction of |
|
(IRS Employer Identification No.) |
300 Elliott Avenue West, Suite 500, Seattle, Washington 98119-4114
(Address of principal executive offices)
Registrants telephone number, including area code: (206) 281-7001
Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
|
Yes |
|
ý |
|
No |
|
o |
Indicate by check mark whether the Registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act.
|
Yes |
|
o |
|
No |
|
ý |
As of November 7, 2003, 27,943,132 shares of the Registrants common stock, $.02 par value per share, were outstanding.
TABLE OF CONTENTS
QUARTERLY
REPORT ON FORM 10-Q
FOR THE QUARTER ENDED SEPTEMBER 30, 2003
2
NEORX CORPORATION AND SUBSIDIARY
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share data)
(unaudited)
|
|
|
September 30, 2003 |
|
December 31, 2002 |
|
||
|
|
|
|
|
|
|
||
|
ASSETS |
|
|
|
|
|
||
|
Current assets: |
|
|
|
|
|
||
|
Cash and cash equivalents |
|
$ |
2,390 |
|
$ |
6,564 |
|
|
Investment securities |
|
13,350 |
|
9,572 |
|
||
|
Prepaid expenses and other current assets |
|
955 |
|
1,269 |
|
||
|
Total current assets |
|
16,695 |
|
17,405 |
|
||
|
|
|
|
|
|
|
||
|
Facilities and equipment, net |
|
8,117 |
|
8,509 |
|
||
|
Other assets, net |
|
67 |
|
79 |
|
||
|
|
|
|
|
|
|
||
|
Total assets |
|
$ |
24,879 |
|
$ |
25,993 |
|
|
|
|
|
|
|
|
||
|
LIABILITIES AND SHAREHOLDERS EQUITY |
|
|
|
|
|
||
|
Current liabilities: |
|
|
|
|
|
||
|
Accounts payable |
|
$ |
653 |
|
$ |
1,024 |
|
|
Accrued liabilities |
|
832 |
|
1,674 |
|
||
|
Current portion of note payable |
|
348 |
|
512 |
|
||
|
Total current liabilities |
|
1,833 |
|
3,210 |
|
||
|
|
|
|
|
|
|
||
|
Long-term liabilities: |
|
|
|
|
|
||
|
Note payable, net of current portion |
|
5,062 |
|
5,182 |
|
||
|
Asset retirement obligation |
|
514 |
|
|
|
||
|
Other |
|
|
|
25 |
|
||
|
Total long-term liabilities |
|
5,576 |
|
5,207 |
|
||
|
|
|
|
|
|
|
||
|
Shareholders equity: |
|
|
|
|
|
||
|
Preferred stock, $.02 par value, 3,000,000 shares authorized: |
|
|
|
|
|
||
|
Convertible preferred stock, Series 1, 205,340 shares issued and outstanding at September 30, 2003 and December 31, 2002 (entitled in liquidation to $5,300 and $5,175, respectively, at September 30, 2003 and December 31, 2002) |
|
4 |
|
4 |
|
||
|
Common stock, $.02 par value, 60,000,000 shares authorized, 27,696,623 and 26,765,082 shares issued and outstanding at September 30, 2003 and December 31, 2002, respectively |
|
554 |
|
535 |
|
||
|
Accumulated other comprehensive income unrealized loss on investment securities |
|
(19 |
) |
(101 |
) |
||
|
Additional paid-in capital |
|
226,115 |
|
224,035 |
|
||
|
Accumulated deficit |
|
(209,184 |
) |
(206,897 |
) |
||
|
Total shareholders equity |
|
17,470 |
|
17,576 |
|
||
|
Total liabilities and shareholders equity |
|
$ |
24,879 |
|
$ |
25,993 |
|
See accompanying notes to the condensed consolidated financial statements.
3
NEORX CORPORATION AND SUBSIDIARY
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(unaudited)
|
|
|
Three
Months Ended |
|
Nine
Months Ended |
|
||||||||
|
|
|
2003 |
|
2002 |
|
2003 |
|
2002 |
|
||||
|
|
|
|
|
|
|
|
|
|
|
||||
|
Revenues |
|
$ |
225 |
|
$ |
507 |
|
$ |
10,531 |
|
$ |
2,036 |
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
||||
|
Research and development |
|
2,037 |
|
4,438 |
|
7,376 |
|
17,472 |
|
||||
|
General and administrative |
|
1,142 |
|
1,535 |
|
4,742 |
|
5,137 |
|
||||
|
Asset impairment loss |
|
|
|
5,658 |
|
|
|
5,658 |
|
||||
|
Restructuring |
|
|
|
529 |
|
|
|
529 |
|
||||
|
Total operating expenses |
|
3,179 |
|
12,160 |
|
12,118 |
|
28,796 |
|
||||
|
Loss from operations |
|
(2,954 |
) |
(11,653 |
) |
(1,587 |
) |
(26,760 |
) |
||||
|
Other income (expense): |
|
|
|
|
|
|
|
|
|
||||
|
Realized gain (loss) on sale of securities |
|
(142 |
) |
20 |
|
(142 |
) |
142 |
|
||||
|
Interest income |
|
30 |
|
204 |
|
184 |
|
912 |
|
||||
|
Interest expense |
|
(57 |
) |
(75 |
) |
(177 |
) |
(281 |
|||||